Showing results (61-70 of 141) with videos related to

Sort By:
Pageof 15
Cancer Research|September 17, 2024
mLumiOpto Is a Mitochondrial-Targeted Gene Therapy for Treating CancerKai Chen, Patrick Ernst, Anusua Sarkar, et al.
Proteomics|July 14, 2011
High-sensitivity TFA-free LC-MS for profiling histonesJia You, Liwen Wang, Motoyasu Saji, et al.
The Journal of Clinical Endocrinology and Metabolism|February 25, 2015
A novel dual AMPK activator/mTOR inhibitor inhibits thyroid cancer cell growthRobert L Plews, Adlina Mohd Yusof, Chaojie Wang, et al.
Thyroid : Official Journal of the American Thyroid Association|December 20, 2002
Vascular endothelial growth factor monoclonal antibody inhibits growth of anaplastic thyroid cancer xenografts in nude miceAndrew J Bauer, Richard Terrell, Nalinikrishna K Doniparthi, et al.
The Journal of Clinical Endocrinology and Metabolism|July 7, 2005
KiSS-1/G protein-coupled receptor 54 metastasis suppressor pathway increases myocyte-enriched calcineurin interacting protein 1 expression and chronically inhibits calcineurin activityNikolaos Stathatos, Isabelle Bourdeau, Allan V Espinosa, et al.
The Journal of Clinical Endocrinology and Metabolism|July 27, 2016
Genome-Wide Expression Screening Discloses Long Noncoding RNAs Involved in Thyroid CarcinogenesisSandya Liyanarachchi, Wei Li, Pearlly Yan, et al.
American Journal of Human Genetics|April 30, 2024
Telomere-lengthening germline variants predispose to a syndromic papillary thyroid cancer subtypeEmily A DeBoy, Anna M Nicosia, Sandya Liyanarachchi, et al.
Thyroid : Official Journal of the American Thyroid Association|January 27, 2026
Identification of Rare Noncoding Variants in Familial Nonmedullary Thyroid CarcinomaDaniel F Comiskey, Sandya Liyanarachchi, Joyce Wu, et al.
The Journal of Clinical Endocrinology and Metabolism|February 28, 2024
Indolent Behavior of Malignant Bethesda III Nodules Compared to Bethesda V/VI NodulesMayumi Endo, Jing Peng, Fadi A Nabhan, et al.
Pageof 15